Nidhi Singh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Nidhi Singh has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Alok Kumar
Analytical Sciences and Accredited Testing Services Group, Analytical Sciences & Services, Industrial Support through Technological Solutions (ASSIST) Division, CSIR-Indian Institute of Toxicology Research (CSIR-IITR), Vishvigyan Bhawan Campus, 31, M.G. Marg, Lucknow 226001, Uttar Pradesh, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India
1 shared publication- Ankit Singla
Chiba University
1 shared publication Anubroto Pal
Department of Pharmacology, National Institute of Pharmaceutical Education and Research, Kolkata, India
1 shared publicationBhamare Kumudini Kishor
1 shared publicationBhaveshkumar Zapadia
Central Animal Facility, National Institute of Pharmaceutical Education and Research, Kolkata, India
1 shared publication- Citu Citu
Center for Precision Health, McWilliams School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA
1 shared publication
Latest Publications
- Top Cited PapersOpen Access
- 15 December 2022
- Published by MDPI AG in Pharmaceutics
- Vol. 14 (12) , 2818
Improved Topical Drug Delivery: Role of Permeation Enhancers and Advanced Approaches
The delivery of drugs via transdermal routes is an attractive approach due to ease of administration, bypassing of the first-pass metabolism, and the large skin surface area. However, a major drawback is an inability to surmount the skin’s stratum corneum (SC) layer. Therefore, techniques reversibly modifying the stratum corneum have been a classical approach. Surmounting the significant barrier properties of the skin in a well-organised, momentary, and harmless approach is still challenging. Chemical permeation enhancers (CPEs) with higher activity are associated with certain side effects restricting their advancement in transdermal drug delivery. Furthermore, complexity in the interaction of CPEs with the skin has led to difficulty in elucidating the mechanism of action. Nevertheless, CPEs-aided transdermal drug delivery will accomplish its full potential due to advancements in analytical techniques, synthetic chemistry, and combinatorial studies. This review focused on techniques such as drug–vehicle interaction, vesicles and their analogues, and novel CPEs such as lipid synthesis inhibitors (LSIs), cell-penetrating peptides (CPPs), and ionic liquids (ILs). In addition, different types of microneedles, including 3D-printed microneedles, have been focused on in this review.
- 15 December 2022
- Published by MDPI AG in Pharmaceutics
- Vol. 14 (12) , 2818
Top Cited PapersOpen AccessImproved Topical Drug Delivery: Role of Permeation Enhancers and Advanced Approaches
The delivery of drugs via transdermal routes is an attractive approach due to ease of administration, bypassing of the first-pass metabolism, and the large skin surface area. However, a major drawback is an inability to surmount the skin’s stratum corneum (SC) layer. Therefore, techniques reversibly modifying the stratum corneum have been a classical approach. Surmounting the significant barrier properties of the skin in a well-organised, momentary, and harmless approach is still challenging. Chemical permeation enhancers (CPEs) with higher activity are associated with certain side effects restricting their advancement in transdermal drug delivery. Furthermore, complexity in the interaction of CPEs with the skin has led to difficulty in elucidating the mechanism of action. Nevertheless, CPEs-aided transdermal drug delivery will accomplish its full potential due to advancements in analytical techniques, synthetic chemistry, and combinatorial studies. This review focused on techniques such as drug–vehicle interaction, vesicles and their analogues, and novel CPEs such as lipid synthesis inhibitors (LSIs), cell-penetrating peptides (CPPs), and ionic liquids (ILs). In addition, different types of microneedles, including 3D-printed microneedles, have been focused on in this review.
- 12 November 2019
- Published by Springer Nature
- p. 59-71
Aptamer: Apt System for Target-Specific Drug Delivery
- 12 November 2019
- Published by Springer Nature
- p. 59-71
Aptamer: Apt System for Target-Specific Drug Delivery